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Background: Multidrug-resistant Gram-negative bacteria
pose a problem that infection control practitioners, hospi-
tal epidemiologists, clinicians, and hospital administrators
are struggling to control. Failure of treatments (or failure
of medical management of infections) with single antibi-
otics which are commonly used in Sudan is associated with
dramatic increases in the Minimum Inhibitory Concentration
(MIC).
Achieving effective combinations of the commonly used
antibiotics may kill resistant mutants, potentiating suc-
cessful therapy. Theoretically and indeed in practice the
Minimum Inhibitory Concentrations (MICs) of antibiotics can
be reduced if combined with a second antibiotic acting syn-
ergistically or additively.
Methods: Ten clinical drug resistant Gram negative bac-
terial isolates were selected for this study. They belong to
four genera namely, Escherichia, Klebsiella, Pseudomonas
and Enterobacter. A sensitive strain of Pasteurella multo-
cida was selected for comparison. The eleven isolates were
identiﬁed using normal biochemical reactions and were con-
ﬁrmed using API 20E kits.
The MIC’s for the isolates were determined for nine
antibiotics alone (singly), and in the presence of a sec-
ond one. They were amoxicillin, ampicillin, cephalexin,
ciproﬂoxacin, cloxacillin, erythromycin, sulphamethoxa-
zole, tetracycline and trimethoprim. Different concentra-
tions of MIC, 0.5 X MIC, 1 X MIC and 2 X MIC along
time was used to determine the effect of concentra-
tion and time on the isolates. The combinations studied
were:-
(i)Ampicillin with ciproﬂoxacin, (ii)ampicillin with amoxi-
cillin, (iii)ampicillin with cloxacillin, (iv)sulphamethaxazole
with trimethoprim, (v)cephalexin with ciproﬂoxacin,
(vi)cephalexin with amoxicillin, (vii)tetracycline with
erythromycin, (viii)tetracycline with amoxicillin,
(ix)tetracycline with sulphamethoxazole, (x)tetracycline
with ciproﬂoxacin and (xi)tetracycline with trimethoprim.
Results: Eight strains were found to have high MICs.
Pseudomonas aeruginosa and Pasteurella multocida were
sensitive to ciproﬂoxacin while the latter was sensitive to
cloxacillin and erythromycin as well. Using different con-
centrations of MIC, 0.5 X MIC, 1 X MIC and 2 X MIC along time
indicated that resistance to ciproﬂoxacin might not be a fre-
quent occurrence if adequate multiples of the MIC for the
infecting organism were obtained in serum and tissue. How-
ever, using sub-inhibitory concentrations of ciproﬂoxacin
against Klebsiella sp. and Pseudomonas aeruginosa may
lead to emergence of resistant strains. Trimethoprim along
time has a bacteriostatic effect on strains of E. coli,
Klebsiella pneumoniae and Enterobacter. Tetracycline had
bacteriostatic effect at low concentrations and bacterio-
cidal effect at high concentrations against some strains of
E. coli and Pasteurella multocida, while erythromycin was
always bacteriostatic against Klebsiella pneumoniae and did
not change to bacteriocidal at high concentrations.
For some strains, the MICs of certain antibiotics were
successfully reduced in the presence of another antibi-
otic. Eleven combinations were studied. As expected, some
antibiotics caused no reduction in the MIC, as they were not
active against the organisms.
The combination of erythromycin and tetracycline was
synergistic and had bacteriocidal effect against some strains
of E. coli, Enterobacter, Pseudomonas aeruginosa and Pas-
teurella multocida. A combination of tetracycline and
ciproﬂoxacin was synergistic and has bacteriostatic effect
on Klebsiella pneumoniae and Enterobacter. Using ampi-
cillin in combination with ciproﬂoxacin against Klebsiella
pneumoniae and Pseudomonas aeruginosa had synergis-
tic as well as bacteriocidal effect on both isolates.
Using cephalexin in combination with ciproﬂoxacin against
Klebsiella pneumoniae had synergistic and bacterioci-
dal effect. Sulphamethoxazole with trimethoprim had
synergistic and bacteriostatic effect on Pseudomonas aerug-
inosa. A combination of the two penicillins ampicillin and
amoxicillin showed bacteriocidal and synergistic effects
against Klebsiella pneumoniae along time. Tetracycline and
trimethoprim combination was antagonistic against Kleb-
siella pneumoniae and Pseudomonas aeruginosa.
Conclusion: It is recommended that every combination of
antibiotics should be tested in vitro with regard to its action
characteristics, to avoid undesirable effects of combina-
tions. Practical clinical experiences are needed to decide
on possible clinical beneﬁts of using any two antibiotics
in combination. Requests for testing combinations could,
therefore, be directed at excluding antagonistic effects
between two antimicrobial agents.
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South Africa
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Background: Klebsiella pneumoniae is an important
organisms causing nosocomial infections in hospitals and in
recent years an increase in reports on plasmid-mediated
extended-spectrum-beta-lactamases (ESBLs) of the CTX-M-
type is noticed. ESBLs are ˇ-lactamase enzymes which
hydrolyse oxyimino cephalosporins and are inhibited ˇ-
lactamase inhibitors such as clavulanic acid or tazobactam.
CTX-M-type ESBLs in K. pneumoniae in South Africa was
ﬁrst reported in 2003, but recent studies found no blaCTX-
M genes amongst isolated from a hospital in Pretoria. The
aim of this study was to examine the presence of blaCTX-M
genes in ESBL producing K.pneumoniae isolates from speci-
mens from patients in an academic hospital in Bloemfontein,
South Africa.
Method: Thirty six K. pneumoniae isolated were col-
lected, six from neonates during an outbreak in 2004 and
30 from patients from the Universitas Academic Hospital,
Bloemfontein from during 2006. ESBL strains were distin-
